Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.

Mogashoa T, Melamu P, Derendinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, Mokomane M, Kgwaadira B, Rankgoane-Pono G, Tsholofelo TT, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

Pathogens. 2019 Oct 28;8(4). pii: E208. doi: 10.3390/pathogens8040208.

2.

Clinical and Virological Outcomes of TB/HIV Coinfected Patients Treated With Dolutegravir-Based HIV Antiretroviral Regimens: Programmatic Experience From Botswana.

Modongo C, Wang Q, Dima M, Matsiri O, Kgwaadira B, Rankgoane-Pono G, Shin SS, Zetola NM.

J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):111-115. doi: 10.1097/QAI.0000000000002126.

PMID:
31335593
3.

Relationship between combination antiretroviral therapy regimens and diabetes mellitus-related comorbidities among HIV patients in Gaborone Botswana.

Tshikuka JG, Rankgoane-Pono G, Magafu MGMD, Masupe T, Molefi M, Nsikungu-Kalukul M, Tlhakanelo JT, Hamda SG, Setlhare V.

BMC Public Health. 2018 Apr 10;18(1):464. doi: 10.1186/s12889-018-5232-0.

4.

Incidence of diabetes mellitus-related comorbidities among patients attending two major HIV clinics in Botswana: a 12-year retrospective cohort study.

Rankgoane-Pono G, Tshikuka JG, Magafu MGMD, Masupe T, Molefi M, Hamda SG, Setlhare V, Tapera R, Mbongwe B.

BMC Res Notes. 2018 Feb 1;11(1):90. doi: 10.1186/s13104-018-3144-9.

Supplemental Content

Loading ...
Support Center